Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities at the J.P. Morgan Healthcare Conference

Anticipated 2024 milestones include: present reni-cel clinical data updates mid-year and year-end, initiate the RUBY clinical trial adolescent cohort, establish in vivo preclinical proof-of-concept...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,San Francisco ,California ,United States ,Gilmore Oneill ,Harvard University Cas ,Broad Institute ,Editas Medicine Inc ,Exchange Commission ,Nasdaq ,Broad Institute Cas ,Vertex Pharmaceuticals ,Healthcare Conference ,Gilmoreo Neill ,Chief Executive Officer ,Editas Medicine ,Harvard University ,Private Securities Litigation Reform Act ,Annual Report ,Markets ,